tradingkey.logo

KORU Medical Systems Inc

KRMD

3.920USD

-0.030-0.76%
Fechamento 09/25, 16:00ETCotações atrasadas em 15 min
181.24MValor de mercado
PerdaP/L TTM

KORU Medical Systems Inc

3.920

-0.030-0.76%
Mais detalhes de KORU Medical Systems Inc Empresa
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. The devices are used for infusions administered at home and in alternate care settings. Its infusion devices work together as a system to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD) and chronic inflammatory demyelinating polyneuropathy (CIDP). The FREEDOM System operates at a lower pressure than an electrical, volumetric pump and maintains a balance between what a patient’s subcutaneous tissues can tolerate and what the system delivers.
Informações da empresa
Código da empresaKRMD
Nome da EmpresaKORU Medical Systems Inc
Data de listagemOct 27, 1993
CEOMs. Linda M. Tharby
Número de funcionários80
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 27
Endereço100 Corporate Drive
CidadeMAHWAH
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal07430
Telefone18454692042
Sitehttps://www.korumedical.com/
Código da empresaKRMD
Data de listagemOct 27, 1993
CEOMs. Linda M. Tharby
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Mr. Edward Wholihan
Mr. Edward Wholihan
Director
Director
37.77K
+12.47%
Mr. Thomas (Tom) Adams
Mr. Thomas (Tom) Adams
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
--
--
Mr. Joseph M. Manko, Jr., J.D.
Mr. Joseph M. Manko, Jr., J.D.
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Linda M. Tharby
Ms. Linda M. Tharby
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.09M
+16.34%
Mr. Adam Kalbermatten
Mr. Adam Kalbermatten
Chief Commercial Officer
Chief Commercial Officer
300.00K
--
Mr. Shahriar (Shar) Matin
Mr. Shahriar (Shar) Matin
Independent Director
Independent Director
87.60K
+5.02%
Dr. Donna French, Ph.D.
Dr. Donna French, Ph.D.
Independent Director
Independent Director
84.97K
+5.19%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
84.61K
+5.21%
Mr. Christopher (Chris) Pazdan
Mr. Christopher (Chris) Pazdan
Chief Operating Officer
Chief Operating Officer
49.99K
+116.54%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
Por RegiãoUSD
Nome
Receita
Proporção
Domestic
7.21M
74.79%
International
2.43M
25.21%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Domestic Core
6.93M
71.90%
International Core
2.43M
25.21%
Novel Therapies
278.45K
2.89%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
Outro
60.34%
Investidores
Investidores
Proporção
Horton Capital Management LLC
12.70%
First Light Asset Management, LLC
10.13%
Topline Capital Management, LLC
7.80%
Tharby (Linda M)
4.52%
The Vanguard Group, Inc.
4.51%
Outro
60.34%
Tipos de investidores
Investidores
Proporção
Hedge Fund
23.51%
Investment Advisor/Hedge Fund
17.47%
Investment Advisor
13.19%
Individual Investor
8.29%
Pension Fund
0.92%
Research Firm
0.47%
Bank and Trust
0.09%
Insurance Company
0.03%
Outro
36.03%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
181
28.37M
61.38%
+1.59M
2025Q1
185
26.98M
58.55%
-3.80M
2024Q4
166
28.05M
61.23%
-2.99M
2024Q3
157
26.45M
57.75%
-1.49M
2024Q2
155
27.99M
61.12%
-3.90M
2024Q1
138
29.57M
64.66%
-1.94M
2023Q4
141
31.83M
69.81%
-3.05M
2023Q3
138
32.73M
71.92%
-2.69M
2023Q2
140
33.07M
72.70%
-1.19M
2023Q1
149
31.99M
70.39%
-2.55M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Horton Capital Management LLC
5.87M
12.73%
-16.19K
-0.27%
Apr 02, 2025
First Light Asset Management, LLC
4.71M
10.22%
+259.46K
+5.82%
Apr 30, 2025
Topline Capital Management, LLC
3.82M
8.28%
-505.93K
-11.69%
Mar 31, 2025
Tharby (Linda M)
2.09M
4.53%
+293.63K
+16.34%
Apr 21, 2025
The Vanguard Group, Inc.
1.76M
3.82%
+6.48K
+0.37%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
181.51K
0.39%
-323.00
-0.18%
Mar 31, 2025
Geode Capital Management, L.L.C.
495.27K
1.07%
+32.09K
+6.93%
Mar 31, 2025
Meros Investment Management, LP
746.56K
1.62%
-18.99K
-2.48%
Mar 31, 2025
Archon Capital Management LLC
566.87K
1.23%
+377.97K
+200.09%
Mar 31, 2025
Manko (Joseph M JR)
517.20K
1.12%
--
--
Apr 02, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI